search:v2 receptor antagonist相關網頁資料

瀏覽:512
日期:2024-09-27
Vasopressin V2-receptor antagonists in patients with cirrhosis, ascites and hyponatremia. Shahid Habib. Department of Medicine, Section of Gastroenterology ......
瀏覽:952
日期:2024-09-30
The non-peptide vasopressin antagonists (VPA), called vaptans, were developed in the 1990s to ... V2 receptors are located in the collecting tubular renal cells....
瀏覽:720
日期:2024-09-27
Effects of vasopressin via V1a- and V2-receptors are closely implicated in a ... The vaptans are vasopressin receptor antagonists with V1a (relcovaptan) or V2 ......
瀏覽:1376
日期:2024-09-29
2006年11月16日 - Original Article from The New England Journal of Medicine — Tolvaptan, a Selective Oral Vasopressin V2-Receptor Antagonist, for ......
瀏覽:558
日期:2024-10-04
Vasopressin antagonists are drugs that bind to vasopressin receptors (V1A, V1B and V2) and block the action of vasopressin (antidiuretic hormone, ADH), which ......
瀏覽:630
日期:2024-09-27
The first nonpeptide vasopressin receptor antagonist (VRA) is now approved by ... combined V1a/V2 receptor blocker conivaptan and the selective V2 receptor ......
瀏覽:772
日期:2024-09-29
2012年3月13日 - Vasopressin receptor antagonists (Vaptans) are a new group of .... The main receptor for maintaining water balance is the V2 receptor (V2R) ......
瀏覽:938
日期:2024-09-30
In 2009, an oral vasopressin V2 receptor antagonist, tolvaptan, was also approved for the treatment of euvolemic and hypervolemic hyponatremia. Both of these ......